Gemtuzumab Antibody
Gemtuzumab (CMA-676) is a recombinant humanized IgG4 monoclonal antibody targeting the CD33 antigen. It serves as the antibody component for constructing the ADC gemtuzumab ozogamicin and is widely used in acute myeloid leukemia research, including in vitro cytotoxicity assays and in vivo xenograft model studies.
Product Specifications
Product Name Alternative
Gemtuzumab, ADCAntibody, ADC Antibody, CMA 676, CMA676, CMA-676, CDP 771, CDP771, CDP-771
Target
ADC Antibody
Clonality
Recombinant
Conjugation
Unconjugated
Concentration
4.59 mg/mL
Purity
95.50% (May vary between batches)
Molecular Weight
145.2 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV713626 1.0 µg DNA
POP4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 
137670-PE 100 µL
CD21 (Complement Receptor Type 2, Cr2, Complement C3d Receptor, Epstein-Barr Virus Receptor, EBV Receptor, CR2, C3DR, SLEB9) (PE) discontinued
Sign In for Pricing
View Details 